Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 118040
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118040
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118040
Table 4 Univariate and multivariate regression analysis to identify significant risk factors of progression of hepatic encephalopathy (hepatic encephalopathy ≥ grade 2)
| Parameters | Univariate hazard ratio by the Cox regression model | Multivariate hazard ratio | ||
| HR (95%CI) | P value | HR (95%CI) | P value | |
| Age | 1.009 (0.986-1.032) | 0.441 | ||
| Hemoglobin | 1.005 (0.888-1.138) | 0.937 | ||
| TLC | 1.000 (1.000-1.000) | 0.055 | ||
| Platelets | 1.000 (1.000-1.000) | 0.163 | ||
| Blood urea | 1.019 (1.000-1.038) | 0.056 | ||
| Creatinine | 3.800 (1.760-8.208) | 0.0007 | 1.293 (0.431-3.880) | 0.646 |
| Total protein | 0.634 (0.475-0.845) | 0.002 | 0.951 (0.647-1.399) | 0.800 |
| Serum albumin | 0.497 (0.315-0.784) | 0.003 | 1.123 (0.590-2.139) | 0.724 |
| Total bilirubin | 1.092 (1.043-1.144) | 0.0002 | 0.924 (0.825-1.034) | 0.169 |
| AST | 1.006 (1.003-1.008) | 0.0002 | 1.004 (0.999-1.008) | 0.523 |
| ALT | 1.003 (0.998-1.009) | 0.221 | ||
| ALP | 1.002 (0.99-1.005) | 0.279 | ||
| Na | 0.945 (0.901-0.992) | 0.022 | 0.969 (0.914-1.028) | 0.294 |
| K | 0.981 (0.625-1.540) | 0.934 | ||
| INR | 1.925 (1.390-2.664) | 0.0001 | 0.443 (0.202-0.969) | 0.041 |
| Serum ammonia | 1.010 (1.004-1.017) | 0.001 | 0.996 (0.985-1.008) | 0.523 |
| CFF | 0.909 (0.862-0.959) | 0.0004 | 0.942 (0.855-1.039) | 0.232 |
| MELD | 1.122 (1.083-1.161) | < 0.0001 | 1.211 | < 0.0001 |
| Myoinositol peak | 0.059 (0.015-0.234) | 0.0001 | 0.284 (0.023-3.549) | 0.329 |
| Choline peak | 0.211 (0.069-0.645) | 0.006 | 0.687 (0.165-2.858) | 0.606 |
| Glutamine peak | 2.227 (1.244-3.986) | 0.007 | 0.740 (0.287-1.904) | 0.532 |
| TNF-α | 1.012 (1.005-1.020) | 0.002 | 0.997 (0.981-1.012) | 0.668 |
| IL-6 | 1.005 (1.001-1.010) | 0.012 | 0.998 (0.991-1.004) | 0.521 |
| IL-18 | 1.001 (1.000-1.003) | 0.014 | 1.000 (0.997-1.003) | 0.972 |
| Endotoxin | 58.094 (6.844-493.151) | 0.0002 | 0.731 (0.000-1717.320) | 0.937 |
| IL-10 | 1.149 (1.075-1.229) | < 0.0001 | 1.122 (0.906-1.388) | 0.291 |
| IL-12 | 1.089 (1.038-1.142) | 0.0004 | 0.786 (0.623-0.990) | 0.041 |
| IL-1β | 1.116 (1.057-1.179) | 0.0001 | 1.142 (0.926-1.410) | 0.215 |
| Gender | ||||
| Female | 1 | |||
| Male | 1.357 (0.647-2.844) | 00.419 | ||
| CTP grade | ||||
| A | 1 | |||
| B | 1.46E+03 (0.000-1.20E+71) | 0.927 | ||
| C | 5.57E+03 (0.000-4.57E+71) | 0.914 | ||
| Grade of HE | ||||
| No HE | 1 | |||
| Minimal HE | 2.783 (1.330-5.822) | 0.007 | 1.499 (0.327-6.878) | 0.603 |
| Grade 1 HE | 4.200 (2.056-8.580) | 0.0001 | 2.23 | 00.02 |
- Citation: Kummetha LC, Bhatt S, Vaithiyam V, Sharma BC, Srivastava S, Mahajan B, Bansal K, Chaudhry N, Tandon MS, Sachdeva S, Kumar A, Dalal A, Sonika U. Differentiation of minimal and grade 1 hepatic encephalopathy using neurophysiological, neuropsychological, magnetic resonance spectroscopic, and systemic inflammatory parameters. World J Hepatol 2026; 18(5): 118040
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/118040.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.118040